P

Peijia Medical Ltd
HKEX:9996

Watchlist Manager
Peijia Medical Ltd
HKEX:9996
Watchlist
Price: 3.88 HKD 0.52% Market Closed
Market Cap: 2.5B HKD
Have any thoughts about
Peijia Medical Ltd?
Write Note

Peijia Medical Ltd
Capital Expenditures

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Peijia Medical Ltd
Capital Expenditures Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Capital Expenditures CAGR 3Y CAGR 5Y CAGR 10Y
P
Peijia Medical Ltd
HKEX:9996
Capital Expenditures
-ÂĄ316.2m
CAGR 3-Years
-125%
CAGR 5-Years
-107%
CAGR 10-Years
N/A
A
APT Medical Inc
SSE:688617
Capital Expenditures
-ÂĄ202m
CAGR 3-Years
-66%
CAGR 5-Years
-44%
CAGR 10-Years
N/A
J
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SZSE:002223
Capital Expenditures
-ÂĄ97.5m
CAGR 3-Years
50%
CAGR 5-Years
26%
CAGR 10-Years
2%
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
Capital Expenditures
-ÂĄ2.5B
CAGR 3-Years
-23%
CAGR 5-Years
-30%
CAGR 10-Years
N/A
J
Jafron Biomedical Co Ltd
SZSE:300529
Capital Expenditures
-ÂĄ302.8m
CAGR 3-Years
17%
CAGR 5-Years
-6%
CAGR 10-Years
N/A
Shanghai United Imaging Healthcare Co Ltd
SSE:688271
Capital Expenditures
-ÂĄ1.1B
CAGR 3-Years
-15%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Peijia Medical Ltd
Glance View

Market Cap
2.6B HKD
Industry
Health Care

Peijia Medical Ltd. engages in the manufacture and sale of medical devices. The company is headquartered in Suzhou, Jiangsu. The company went IPO on 2020-05-15. Through its subsidiaries, the Company operates two segments. Transcatheter Valve Therapeutic Business segment is mainly engaged in the development of transcatheter valve therapeutic medical devices. Neurointerventional Business segment is engaged in the research and development of neurointerventional procedural medical devices. The firm's main products under development include TaurusOne, TaurusElite, TaurusNXT and others. The firm operates its businesses primarily in domestic market.

Intrinsic Value
5.28 HKD
Undervaluation 27%
Intrinsic Value
Price
P

See Also

What is Peijia Medical Ltd's Capital Expenditures?
Capital Expenditures
-316.2m CNY

Based on the financial report for Dec 31, 2023, Peijia Medical Ltd's Capital Expenditures amounts to -316.2m CNY.

What is Peijia Medical Ltd's Capital Expenditures growth rate?
Capital Expenditures CAGR 5Y
-107%

Over the last year, the Capital Expenditures growth was -56%. The average annual Capital Expenditures growth rates for Peijia Medical Ltd have been -125% over the past three years , -107% over the past five years .

Back to Top